Redox regulation of metabolic syndrome: recent developments in skeletal muscle insulin resistance and non-alcoholic fatty liver disease (NAFLD)

Bonnard, 2008, Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice, J Clin Invest, 118, 789 Ferreira, 2016, Regulation of NADPH oxidases in skeletal muscle, Free Radic Biol Med, 98, 18, 10.1016/j.freeradbiomed.2016.05.011 Wei, 2006, Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells, J Biol Chem, 281, 35137, 10.1074/jbc.M601320200 Ohta, 2011, Oxidative stress impairs insulin signal in skeletal muscle and causes insulin resistance in postinfarct heart failure, Am J Physiol Heart Circ Physiol, 300, H1637, 10.1152/ajpheart.01185.2009 Souto Padron de Figueiredo, 2015, Nox2 mediates skeletal muscle insulin resistance induced by a high fat diet, J Biol Chem, 290, 13427, 10.1074/jbc.M114.626077 Bravard, 2011, Inhibition of xanthine oxidase reduces hyperglycemia-induced oxidative stress and improves mitochondrial alterations in skeletal muscle of diabetic mice, Am J Physiol Endocrinol Metab, 300, E581, 10.1152/ajpendo.00455.2010 Miric, 2016, Xanthine oxidase activity in type 2 diabetes mellitus patients with and without diabetic peripheral neuropathy, J Diabetes Res, 2016, 10.1155/2016/4370490 Moriya, 2018, Febuxostat improves insulin resistance in the skeletal muscle in vitro and in vivo, Diabetes, 67, 10.2337/db18-1927-P Barquissau, 2017, Reactive oxygen species enhance mitochondrial function, insulin sensitivity and glucose uptake in skeletal muscle of senescence accelerated prone mice SAMP8, Free Radic Biol Med, 113, 267, 10.1016/j.freeradbiomed.2017.10.012 Di Meo, 2017, Skeletal muscle insulin resistance: role of mitochondria and other ROS sources, J Endocrinol, 233, R15, 10.1530/JOE-16-0598 Szendroedi, 2009, Impaired mitochondrial function and insulin resistance of skeletal muscle in mitochondrial diabetes, Diabetes Care, 32, 677, 10.2337/dc08-2078 Maurya, 2015, NOD2 activation induces oxidative stress contributing to mitochondrial dysfunction and insulin resistance in skeletal muscle cells, Free Radic Biol Med, 89, 158, 10.1016/j.freeradbiomed.2015.07.154 Ribas, 2016, Skeletal muscle action of estrogen receptor alpha is critical for the maintenance of mitochondrial function and metabolic homeostasis in females, Sci Transl Med, 8, 10.1126/scitranslmed.aad3815 Jing, 2011, Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production, Proc Natl Acad Sci U S A, 108, 14608, 10.1073/pnas.1111308108 Lai, 2016, SIRT3-AMP-activated protein kinase activation by nitrite and metformin improves hyperglycemia and normalizes pulmonary hypertension associated with heart failure with preserved ejection fraction, Circulation, 133, 717, 10.1161/CIRCULATIONAHA.115.018935 Ioja, 2018, Nocturnal hypoxia improves glucose disposal, decreases mitochondrial efficiency, and increases reactive oxygen species in the muscle and liver of C57BL/6J mice independent of weight change, Oxid Med Cell Longev, 2018, 10.1155/2018/9649608 Shi, 2015, DJ-1 links muscle ROS production with metabolic reprogramming and systemic energy homeostasis in mice, Nat Commun, 6, 10.1038/ncomms8415 Liong, 2016, Endoplasmic reticulum stress regulates inflammation and insulin resistance in skeletal muscle from pregnant women, Mol Cell Endocrinol, 425, 11, 10.1016/j.mce.2016.02.016 Saktiawati, 2016, Impact of food on the pharmacokinetics of first-line anti-TB drugs in treatment-naive TB patients: a randomized cross-over trial, J Antimicrob Chemother, 71, 703, 10.1093/jac/dkv394 Koh, 2013, Tribbles 3 mediates endoplasmic reticulum stress-induced insulin resistance in skeletal muscle, Nat Commun, 4, 10.1038/ncomms2851 Cui, 2019, Iron overload by transferrin receptor protein 1 regulation plays an important role in palmitate-induced insulin resistance in human skeletal muscle cells, FASEB J, 33, 1771, 10.1096/fj.201800448R Mehdad, 2015, Iron deprivation may enhance insulin receptor and Glut4 transcription in skeletal muscle of adult rats, J Nutr Health Aging, 19, 846, 10.1007/s12603-015-0541-9 Qin, 2012, A metagenome-wide association study of gut microbiota in type 2 diabetes, Nature, 490, 55, 10.1038/nature11450 Choi, 2015, Gut microbe-derived extracellular vesicles induce insulin resistance, thereby impairing glucose metabolism in skeletal muscle, Sci Rep, 5, 10.1038/srep15878 Younossi, 2018, Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention, Nat Rev Gastroenterol Hepatol, 15, 11, 10.1038/nrgastro.2017.109 Zeb, 2016, Nonalcoholic fatty liver disease and incident cardiac events: the multi-ethnic study of atherosclerosis, J Am Coll Cardiol, 67, 1965, 10.1016/j.jacc.2016.01.070 Del Ben, 2012, Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences, Intern Emerg Med, 7, S291, 10.1007/s11739-012-0819-4 Buzzetti, 2016, The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD), Metabolism, 65, 1038, 10.1016/j.metabol.2015.12.012 Flannery, 2012, Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly, Diabetes, 61, 2711, 10.2337/db12-0206 Schwarz, 2003, Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets, Am J Clin Nutr, 77, 43, 10.1093/ajcn/77.1.43 Matsumoto, 2018, The NOX1 isoform of NADPH oxidase is involved in dysfunction of liver sinusoids in nonalcoholic fatty liver disease, Free Radic Biol Med, 115, 412, 10.1016/j.freeradbiomed.2017.12.019 Garcia-Ruiz, 2016, NADPH oxidase is implicated in the pathogenesis of oxidative phosphorylation dysfunction in mice fed a high-fat diet, Sci Rep, 6, 10.1038/srep23664 Chatterjee, 2013, Leptin is key to peroxynitrite-mediated oxidative stress and Kupffer cell activation in experimental non-alcoholic steatohepatitis, J Hepatol, 58, 778, 10.1016/j.jhep.2012.11.035 Das, 2015, NADPH oxidase-derived peroxynitrite drives inflammation in mice and human nonalcoholic steatohepatitis via TLR4-lipid raft recruitment, Am J Pathol, 185, 1944, 10.1016/j.ajpath.2015.03.024 Wang, 2017, Involvement of xanthine oxidase and paraoxonase 1 in the process of oxidative stress in nonalcoholic fatty liver disease, Mol Med Rep, 15, 387, 10.3892/mmr.2016.6025 Nakatsu, 2015, The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model, Am J Physiol Gastrointest Liver Physiol, 309, G42, 10.1152/ajpgi.00443.2014 Loffredo, 2016, Effects of dark chocolate on NOX-2-generated oxidative stress in patients with non-alcoholic steatohepatitis, Aliment Pharmacol Ther, 44, 279, 10.1111/apt.13687 Ding, 2017, Emerging roles of SIRT1 in fatty liver diseases, Int J Biol Sci, 13, 852, 10.7150/ijbs.19370 Li, 2018, Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: the role of the ERK-CREB pathway and Bnip3-mediated mitophagy, Redox Biol, 18, 229, 10.1016/j.redox.2018.07.011 Grattagliano, 2012, Role of mitochondria in nonalcoholic fatty liver disease—from origin to propagation, Clin Biochem, 45, 610, 10.1016/j.clinbiochem.2012.03.024 Ucar, 2013, The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis, Redox Rep, 18, 127, 10.1179/1351000213Y.0000000050 Heid, 2013, Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation, J Immunol, 191, 5230, 10.4049/jimmunol.1301490 Mridha, 2017, NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice, J Hepatol, 66, 1037, 10.1016/j.jhep.2017.01.022 Zhang, 2014, Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease, World J Gastroenterol, 20, 1768, 10.3748/wjg.v20.i7.1768 Kim, 2018, ER stress drives lipogenesis and steatohepatitis via caspase-2 activation of S1P, Cell, 175, 133, 10.1016/j.cell.2018.08.020 Wang, 2012, IRE1alpha-XBP1s induces PDI expression to increase MTP activity for hepatic VLDL assembly and lipid homeostasis, Cell Metab, 16, 473, 10.1016/j.cmet.2012.09.003 Xiao, 2013, ATF4 protein deficiency protects against high fructose-induced hypertriglyceridemia in mice, J Biol Chem, 288, 25350, 10.1074/jbc.M113.470526 Yamamoto, 2010, Induction of liver steatosis and lipid droplet formation in ATF6alpha-knockout mice burdened with pharmacological endoplasmic reticulum stress, Mol Biol Cell, 21, 2975, 10.1091/mbc.e09-02-0133 Kim, 2017, Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis, J Hepatol, 67, 349, 10.1016/j.jhep.2017.03.023 Hagstrom, 2016, Elevated serum ferritin is associated with increased mortality in non-alcoholic fatty liver disease after 16 years of follow-up, Liver Int, 36, 1688, 10.1111/liv.13144 Valenzuela, 2018, Iron-induced pro-oxidant and pro-lipogenic responses in relation to impaired synthesis and accretion of long-chain polyunsaturated fatty acids in rat hepatic and extrahepatic tissues, Nutrition, 45, 49, 10.1016/j.nut.2017.07.007 Murali, 2018, Systematic review and meta-analysis to determine the impact of iron depletion in dysmetabolic iron overload syndrome and non-alcoholic fatty liver disease, Hepatol Res, 48, E30, 10.1111/hepr.12921 Marra, 2018, Lipotoxicity and the gut-liver axis in NASH pathogenesis, J Hepatol, 68, 280, 10.1016/j.jhep.2017.11.014 Henao-Mejia, 2012, Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity, Nature, 482, 179, 10.1038/nature10809 Zhu, 2013, Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH, Hepatology, 57, 601, 10.1002/hep.26093 Rodriguez-Carrio, 2017, Free fatty acids profiles are related to gut microbiota signatures and short-chain fatty acids, Front Immunol, 8, 823, 10.3389/fimmu.2017.00823 Sanyal, 2010, Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis, N Engl J Med, 362, 1675, 10.1056/NEJMoa0907929 Mason, 2016, Ascorbic acid supplementation improves skeletal muscle oxidative stress and insulin sensitivity in people with type 2 diabetes: findings of a randomized controlled study, Free Radic Biol Med, 93, 227, 10.1016/j.freeradbiomed.2016.01.006 Honda, 2017, Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study, BMC Gastroenterol, 17, 96, 10.1186/s12876-017-0652-3 Zhu, 2017, Active form of vitamin D ameliorates non-alcoholic fatty liver disease by alleviating oxidative stress in a high-fat diet rat model, Endocr J, 64, 663, 10.1507/endocrj.EJ16-0542 Benetti, 2018, Effects of vitamin D on insulin resistance and myosteatosis in diet-induced obese mice, PLoS One, 13, 10.1371/journal.pone.0189707 Ohtake, 2017, Dietary nitrite reverses features of postmenopausal metabolic syndrome induced by high-fat diet and ovariectomy in mice, Am J Physiol Endocrinol Metab, 312, E300, 10.1152/ajpendo.00360.2016 Jiang, 2014, Dietary nitrite improves insulin signaling through GLUT4 translocation, Free Radic Biol Med, 67, 51, 10.1016/j.freeradbiomed.2013.10.809 Ohtake, 2015, Dietary nitrite supplementation improves insulin resistance in type 2 diabetic KKA(y) mice, Nitric Oxide, 44, 31, 10.1016/j.niox.2014.11.009 Wang, 2018, Inorganic nitrate alleviates the senescence-related decline in liver function, Sci China Life Sci, 61, 24, 10.1007/s11427-017-9207-x van der Veen, 2016, Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice, Am J Physiol Gastrointest Liver Physiol, 310, G526, 10.1152/ajpgi.00243.2015 Shang, 2017, Phenotyping of adipose, liver, and skeletal muscle insulin resistance and response to pioglitazone in spontaneously obese rhesus monkeys, Am J Physiol Endocrinol Metab, 312, E235, 10.1152/ajpendo.00398.2016 Boettcher, 2012, Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis, Aliment Pharmacol Ther, 35, 66, 10.1111/j.1365-2036.2011.04912.x